Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia

被引：0
|
作者：
Yvyin Zhang
Peihong Wang
Yang Wang
Yang Shen
机构：
[1] State Key Laboratory of Medical Genomics,Shanghai Institute of Hematology
[2] National Research Center for Translational Medicine (Shanghai),Department of Hematology
[3] Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,undefined
[4] Guangzhou First People’s Hospital,undefined
[5] School of Medicine,undefined
[6] South China University of Technology,undefined
来源：
Biomarker Research | / 11卷
关键词：
Sitravatinib; -ITD; AML; Gilteritinib; Drug resistance; -ITD-F691L; FL; FGF2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] FLT3 inhibitors in acute myeloid leukemia
    Mei Wu
    Chuntuan Li
    Xiongpeng Zhu
    Journal of Hematology & Oncology, 11
  • [42] FLT3 Inhibitors in Acute Myeloid Leukemia
    Stone, Richard M.
    ONCOLOGIST, 2016, 21 : S2 - S2
  • [43] Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
    Eguchi, Motoki
    Minami, Yosuke
    Kuzume, Ayumi
    Chi, SungGi
    BIOMEDICINES, 2020, 8 (08)
  • [44] FLT3 inhibitors in acute myeloid leukemia
    不详
    ANNALS OF HEMATOLOGY, 2008, 87 : S87 - S89
  • [45] FLT3 Inhibitors for Acute Myeloid Leukemia
    Lancet, Jeffrey E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 573 - 575
  • [46] FLT3 inhibitors in acute myeloid leukemia
    el-Shami, Khaled
    Stone, Richard M.
    Smith, B. Douglas
    EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (02) : 153 - 160
  • [47] FLT3 inhibitors in acute myeloid leukemia
    Pastore, Domenico
    DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2016, 4 (01): : 14 - 21
  • [48] Can FLT3 inhibitors overcome resistance in AML?
    Tam, Winnie F.
    Gilliland, Gary
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (01) : 13 - 20
  • [49] Gilteritinib: potent targeting of FLT3 mutations in AML
    Levis, Mark
    Perl, Alexander E.
    BLOOD ADVANCES, 2020, 4 (06) : 1178 - 1191
  • [50] FLT3 Kinase Inhibitor TTT-3002 Overcomes Both Activating and Drug Resistance Mutations in FLT3 in Acute Myeloid Leukemia
    Ma, Hayley S.
    Bao Nguyen
    Duffield, Amy S.
    Li, Li
    Galanis, Allison
    Williams, Allen B.
    Brown, Patrick A.
    Levis, Mark J.
    Leahy, Daniel J.
    Small, Donald
    CANCER RESEARCH, 2014, 74 (18) : 5206 - 5217
12345